4R.J.Harwood J.B.Schwavtz.Drug Dev Ind Pharm,1982,8:663-663.
5J Folkman ,S Winsey .Auesthesiology,1981,29:410.
6S W Kim ,Zeter. J Pharm Sci,1978,67:1532.
7R Wada ,Hyon S et al Poly Mater Sci Eng 1988,59:803-816.
8D Lemoine ,C Francois ,et al. Stahility study of nanoparticles of poly (e-caprclacione), poly (D,L-lactide) and poly(D,L-lactide-co-glycolide),Biomaterials,1996,17:2191.
9B C Benicewicz ,P K Hopper ,J Bioact Compat Polymer, 1991,6:64.
10G. Forssell,C. Graffner,R. Nordlander,O. Nyquist. Comparative bioavailability of disopyramide after multiple dosing with standard capsules and controlled-release tablets[J] 1980,European Journal of Clinical Pharmacology(3):209～213
